Suppr超能文献

壳聚糖微球包裹的青藤碱经光交联型 GelMA 水凝胶关节腔给药通过有效调控自噬改善骨关节炎。

Intra-articular delivery of sinomenium encapsulated by chitosan microspheres and photo-crosslinked GelMA hydrogel ameliorates osteoarthritis by effectively regulating autophagy.

机构信息

Department of Orthopaedics, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China.

Department of Orthopaedics, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China.

出版信息

Biomaterials. 2016 Mar;81:1-13. doi: 10.1016/j.biomaterials.2015.12.006. Epub 2015 Dec 15.

Abstract

Reduced expression of autophagy regulators has been observed in pathological cartilage in humans and mice. The present study aimed to investigate the synergistic therapeutic effect of promotion of chondrocyte autophagy via exposure to sinomenium (SIN) encapsulated by chitosan microspheres (CM-SIN) and photo-crosslinked gelatin methacrylate (GelMA) hydrogel, with the goal of evaluating CM-SIN as a treatment for patients with osteoarthritis. First, we fabricated and characterized GelMA hydrogels and chitosan microspheres. Next, we measured the effect of SIN on cartilage matrix degradation induced by IL1-β in chondrocytes and an ex vivo model. SIN ameliorated the pathological changes induced by IL1-β at least partially through activation of autophagy. Moreover, we surgically induced osteoarthritis in mice, which were injected intra-articularly with CM-SIN and GelMA. Cartilage matrix degradation and chondrocyte autophagy were evaluated 4 and 8 weeks after surgery. Treatment with the combination of CM-SIN and GelMA retarded the progression of surgically induced OA. SIN ameliorated cartilage matrix degradation at least partially by inducing autophagy in vivo. Our results demonstrate that injection of the combination of GelMA hydrogel and CM-SIN could be a promising strategy for treating patients with osteoarthritis.

摘要

自噬调节剂在人类和小鼠的病理性软骨中表达减少。本研究旨在探讨通过壳聚糖微球(CM-SIN)包封的青藤碱(SIN)暴露促进软骨细胞自噬,与光交联明胶甲基丙烯酸酯(GelMA)水凝胶的协同治疗效果,以期将 CM-SIN 作为治疗骨关节炎患者的方法。首先,我们制备并表征了 GelMA 水凝胶和壳聚糖微球。接下来,我们测量了 SIN 对 IL1-β诱导的软骨细胞和体外模型中软骨基质降解的影响。SIN 通过激活自噬至少部分缓解了 IL1-β 诱导的病理变化。此外,我们通过关节内注射 CM-SIN 和 GelMA 对小鼠进行手术诱导骨关节炎。手术后 4 周和 8 周评估软骨基质降解和软骨细胞自噬。CM-SIN 和 GelMA 的联合治疗延缓了手术诱导的 OA 的进展。SIN 通过在体内诱导自噬至少部分改善了软骨基质降解。我们的结果表明,注射 GelMA 水凝胶和 CM-SIN 的混合物可能是治疗骨关节炎患者的一种有前途的策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验